# Sennoside D

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sennoside-d
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Senna glycoside D, Anthraquinone glycoside D, Rhein-8-glucoside sennoside, Cassia sennoside D, Senna alexandrina sennoside D

## Overview

Sennoside D is a dianthrone glycoside anthraquinone found in senna (Cassia senna) that functions primarily as a stimulant laxative by promoting colonic motility. It is metabolized by gut bacteria into rheinanthrone, the active compound responsible for stimulating intestinal secretion and peristalsis.

## Health Benefits

• Acts as a stimulant laxative, contributing to senna's general use for constipation relief. [4][5]
• May have leukopoietic activity, although clinical evidence is limited. [3]
• Potential ion channel inhibition related to interferon β-diseases, with limited supporting details. [3]
• Part of the bioactive compounds in senna used historically in herbal medicine. [3][4]
• Contributes to the efficacy of senna extracts in standardized forms, though specific concentrations are not provided. [2][3][6]

## Mechanism of Action

Sennoside D is hydrolyzed by colonic bacterial enzymes into rheinanthrone, which irritates the colonic mucosa and stimulates the myenteric plexus to increase peristaltic contractions. Rheinanthrone also inhibits colonic Na+/K+-ATPase activity, reducing water and electrolyte reabsorption and promoting fluid secretion into the lumen. Preliminary data suggest sennoside D may additionally inhibit specific ion channels relevant to interferon β-mediated signaling pathways, though the precise molecular targets remain uncharacterized.

## Clinical Summary

Clinical evidence supporting sennoside D specifically is sparse, as most studies examine senna extract or combined sennosides A and B rather than isolating sennoside D alone. Randomized controlled trials of standardized senna preparations containing sennoside mixtures demonstrate effective laxation at doses of 12–36 mg total sennosides within 6–12 hours, but sennoside D's individual contribution cannot be quantified from this data. Preliminary in vitro studies suggest potential leukopoietic activity, meaning possible stimulation of [white blood cell](/ingredients/condition/immune-support) production, though no human clinical trials have validated this effect. Overall, the evidence base for sennoside D as a distinct therapeutic agent is limited, and its clinical profile is largely inferred from senna phytochemical research.

## Nutritional Profile

Sennoside D is a pure bioactive compound (anthraquinone glycoside), not a whole food ingredient, and therefore has no conventional macronutrient or micronutrient profile. As an isolated compound, it contains no appreciable protein, fat, carbohydrate (beyond its glycoside sugar moiety), vitamins, or dietary minerals. Structurally, it is a dianthrone diglucoside with a molecular weight of approximately 862.8 g/mol, sharing the core rhein-dianthrone backbone common to senna anthraquinones. It occurs as a minor constituent within senna leaf and pod preparations, typically at lower concentrations than the predominant sennosides A and B; sennoside A+B combined usually account for 1.5–3% of dried senna leaf by weight, while sennoside D represents a small fraction of the total anthraquinone glycoside content, estimated at roughly 0.01–0.1% of dried plant material. The compound itself is not bioavailable in its intact glycoside form; it is hydrolyzed by colonic bacterial flora (notably Bifidobacterium and Eubacterium species) into its active metabolite rheinanthrone, which exerts the pharmacological laxative effect on the colon mucosa. No caloric contribution, fiber content, or micronutrient value is attributable to sennoside D as an isolated compound. Its relevance is entirely as a pharmacologically active secondary metabolite rather than a nutritional constituent.

## Dosage & Preparation

No clinically studied dosage ranges for Sennoside D in isolation are specified in the research. It is advised to consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Sennoside D, like other senna anthraquinones, can cause abdominal cramping, diarrhea, electrolyte imbalances particularly hypokalemia, and melanosis coli with prolonged use exceeding 2–4 weeks. It is contraindicated in individuals with intestinal obstruction, [inflammatory](/ingredients/condition/inflammation) bowel disease, appendicitis, or abdominal pain of unknown origin. Drug interactions include reduced absorption of oral medications due to accelerated gut transit, and concurrent use with diuretics or corticosteroids may potentiate hypokalemia risk. Senna-containing compounds including sennoside D are generally avoided during pregnancy, especially in the first trimester, and should be used cautiously during breastfeeding due to potential transfer in breast milk.

## Scientific Research

There are no specific human clinical trials, RCTs, or meta-analyses available for Sennoside D alone. The evidence pertains to sennosides as a group, generally recognized for their laxative effects. No PMIDs are provided for studies specific to Sennoside D.

## Historical & Cultural Context

Sennoside D contributes to the traditional use of senna as an herbal laxative, historically utilized for relieving constipation. This use is derived from dried plant leaflets and pods, though specific traditional systems are not detailed.

## Synergistic Combinations

Senna leaf, Aloe vera, Cascara sagrada, Psyllium husk, Magnesium citrate

## Frequently Asked Questions

### What is sennoside D and how does it differ from sennoside A and B?

Sennoside D is a dianthrone glycoside anthraquinone in senna that differs from sennosides A and B primarily in its stereochemical configuration at the glycosidic bond linkage. While sennosides A and B are the most abundant and studied compounds in standardized senna extracts, sennoside D is a minor constituent sharing the same rheinanthrone metabolite pathway. All three contribute to laxative activity, but commercial senna products are typically standardized to sennosides A and B rather than sennoside D.

### How long does sennoside D take to work as a laxative?

Sennoside D, like other senna anthraquinones, requires colonic bacterial metabolism into rheinanthrone before it becomes pharmacologically active, which accounts for its delayed onset of 6–12 hours after ingestion. This lag time reflects the transit from the small intestine to the colon where anaerobic bacteria perform the necessary hydrolysis. For this reason, senna products containing sennoside D are typically taken at bedtime to produce a bowel movement the following morning.

### Can sennoside D cause electrolyte imbalances?

Yes, sennoside D can contribute to electrolyte disturbances, most notably hypokalemia (low potassium), because its active metabolite rheinanthrone inhibits Na+/K+-ATPase in the colonic mucosa and promotes fluid secretion into the gut lumen. Chronic or excessive use lasting more than 1–2 weeks significantly elevates this risk, particularly in elderly individuals or those taking diuretics or corticosteroids. Monitoring serum electrolytes is recommended for anyone using senna-based laxatives regularly.

### Does sennoside D have any immune or leukopoietic effects?

In vitro and preliminary research suggests sennoside D may possess leukopoietic activity, meaning it could potentially stimulate the production or maturation of white blood cells, but no human clinical trials have confirmed this effect. Additionally, there are early indications of ion channel inhibition relevant to interferon β-related disease pathways, though the specific channels and receptors involved have not been well characterized. These potential immunomodulatory effects remain speculative and should not be considered established health benefits.

### Is sennoside D safe during pregnancy or breastfeeding?

Sennoside D and senna-derived anthraquinones are generally not recommended during pregnancy, particularly in the first trimester, due to potential stimulant effects on uterine smooth muscle and limited safety data in humans. During breastfeeding, small amounts of active anthraquinone metabolites may transfer into breast milk, although studies on standardized senna preparations have shown minimal infant effects at typical therapeutic doses. Healthcare providers typically recommend osmotic laxatives such as polyethylene glycol or lactulose as safer alternatives during pregnancy and lactation.

### What foods or herbs naturally contain sennoside D?

Sennoside D is primarily found in senna plants (Cassia species), particularly Cassia angustifolia and Cassia acutifolia, which are the main botanical sources used in herbal medicine and dietary supplements. While senna leaves and pods are the dominant natural sources, sennoside D is not significantly present in common foods and is obtained almost exclusively through senna-based herbal preparations. Historical use of senna tea and extracts reflects reliance on these specific plant sources rather than dietary intake.

### Does sennoside D interact with common medications or other supplements?

Sennoside D may interact with medications that depend on normal bowel transit time, including oral contraceptives and certain antibiotics, as stimulant laxatives can reduce absorption of drugs in the gastrointestinal tract. Concurrent use with diuretics or potassium-depleting medications may increase the risk of electrolyte imbalances due to sennoside D's laxative effects. It is advisable to space sennoside D supplementation at least 2 hours apart from other oral medications to minimize absorption interference.

### Who should avoid sennoside D supplementation?

Sennoside D should be avoided by individuals with inflammatory bowel conditions (Crohn's disease, ulcerative colitis), abdominal obstruction, or acute appendicitis, as stimulant laxatives can worsen these conditions. Children under 12 years old, individuals with chronic kidney disease, and those with a history of electrolyte disorders should use sennoside D only under medical supervision. People taking medications that affect electrolyte balance or those with dehydration should consult a healthcare provider before using senna-based supplements containing sennoside D.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*